The short version
- Why people research itBone marrow and blood cell production in ageing.
- What the evidence isNo randomized human trials — a research compound with no commercial route to funding one, so the correlative and theoretical tiers are the evidence base rather than a consolation prize.
- What to watchUnexplained bruising, bleeding gums or repeated infections.
How Bonomarlot works
The proposal is tissue specificity: a short peptide fraction taken from one organ acts preferentially on that same organ, binding regulatory DNA sequences and shifting protein synthesis toward a younger pattern.
Khavinson-school organ peptide extracts. The claim is tissue specificity: a short peptide fraction from one organ is proposed to act on that same organ, restoring its protein synthesis toward a younger pattern by binding regulatory DNA sequences. The mechanism is coherent and the human evidence for it is thin outside the group that proposed it.
- Oral
On the goal map: Thymus & immune (Organ-specific bioregulation)
Research on Bonomarlot4 evidence notes: clinical, correlative, mechanism
Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work
Evidence on file: Theoretical — Khavinson-school work, largely Russian-language and rarely replicated outside it.
Human clinical evidence
No randomized human trials — a research compound with no commercial route to funding one, so the correlative and theoretical tiers are the evidence base rather than a consolation prize.
No completed human trial
Correlative data
The Khavinson group reported improvements in organ-specific markers across a long series of studies from the 1980s onward. These are overwhelmingly small, single-arm, and published in Russian-language journals; independent replication outside that school is close to absent.
How the mechanism reads
The proposal is tissue specificity: a short peptide fraction taken from one organ acts preferentially on that same organ, binding regulatory DNA sequences and shifting protein synthesis toward a younger pattern.
MechanisticOral delivery is the open question, not the mechanism. Peptides are poorly absorbed intact from the gut. Whether enough survives to reach the target tissue has not been shown in a way anyone outside the manufacturer can check.
Mechanistic
Sources
- Khavinson VK. Results and Prospects of Using Activator of Hematopoietic Stem Cell Differentiation in Complex Therapy for Patients with COVID-19. Stem Cell Reviews and Reports 2021 · PMID 33575961
- Deigin V. Peptide ILE-GLU-TRP (Stemokin) Potential Adjuvant Stimulating a Balanced Immune Response. International Journal of Peptide Research and Therapeutics 2022 · PMID 36313476
- Ryzhak AP, Chalisova NI, Lin'kova NS, Khalimov RI, Ryzhak GA, Zhekalov AN. [Polypeptides influence on tissue cell cultures regeneration of various age rats]. Advances in Gerontology 2015;28(1):97-103 [Russian] · PMID 26390619
- Khavinson VKh. Peptides tissue-specifically stimulate cell differentiation during their aging. Bulletin of Experimental Biology and Medicine 2012 · PMID 22808515
- Khavinson V, Linkova N, Kozhevnikova E, Dyatlova A, Petukhov M. Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers. International Journal of Molecular Sciences 2022;23(14):7733 · PMID 35887081
- Khavinson VKh, Popovich IG, Linkova NS, Mironova ES, Ilina AR. Peptide Regulation of Gene Expression: A Systematic Review. Molecules 2021;26(22):7053 · PMID 34834147
Bonomarlot safety basicsWho should avoid it, what to expect, what to watch
Avoid if
- Blood cancer or myeloproliferative disease, where stimulating marrow cells is unwanted.
- Unexplained anemia or low counts that have not been investigated.
- Autoimmune disease flaring, because the peptides claim to shift immune cell differentiation.
- Pregnancy or under 18, while marrow and immune cell development are still active.
What’s expected
- Nothing you would feel; the claim is slow gene-expression change in marrow-derived cells.
- Occasional mild gut upset with oral peptide fractions.
- No acute effect on blood counts has been established.
Watch for
- Unexplained bruising, bleeding gums or repeated infections.
- Persistent bone pain.
- Fatigue with pallor that does not lift.
Labs that tell you it’s working
- Complete Blood Count: marrow output of red cells, white cells and platelets is the direct readout.
- Ferritin: separates iron-limited anemia from marrow problems.
- Vitamin B12 & Folate: the other cause of low counts that should be excluded first.
Khavinson-school marrow peptide fraction proposed to bind DNA and shift gene expression in bone-marrow cells; human data are sparse. PMID 33575961 PMID 22808515
Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON
A panel picked from how it works and what it can move: the tests, and why each is on it.
Code CAMERON applies automatically. The before and after schedule and how to read the results are in the Skool lesson.
Bonomarlot FAQ4 common questions
- Is Bonomarlot approved for human use?
- No. Bonomarlot is a research compound. No completed randomized human trial has given it yet.
- What is Bonomarlot researched for?
- Bone marrow and blood cell production in ageing.
- Which labs show whether it's doing anything?
- Complete Blood Count; Ferritin; Vitamin B12 & Folate: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
- Where's the full protocol?
- In the Skool lesson for Bonomarlot: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.



